187 related articles for article (PubMed ID: 33051971)
1. Evaluating an incobotulinumtoxinA and Cohesive Polydensified Matrix
Barbarino SC; Woodward JA; Levine J; Fezza J
J Cosmet Dermatol; 2021 May; 20(5):1459-1466. PubMed ID: 33051971
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the Effect of Incobotulinumtoxin A for Glabellar, Forehead, and Crow's Feet Lines Using A High Dilution.
Barbarino SC; van Loghem JAJ; Burgess CM; Corduff N
J Clin Aesthet Dermatol; 2021 Aug; 14(8):34-40. PubMed ID: 34840655
[TBL] [Abstract][Full Text] [Related]
3. A Randomized, Blinded, Prospective Clinical Study Comparing Small-Particle Versus Cohesive Polydensified Matrix Hyaluronic Acid Fillers for the Treatment of Perioral Rhytids.
Polacco MA; Singleton AE; Luu T; Maas CS
Aesthet Surg J; 2021 May; 41(6):NP493-NP499. PubMed ID: 32506124
[TBL] [Abstract][Full Text] [Related]
4. Cohesive Polydensified Matrix Hyaluronic Acid for the Treatment of Etched-In Fine Facial Lines: A 6-Month, Open-Label Clinical Trial.
Black JM; Gross TM; Murcia CL; Jones DH
Dermatol Surg; 2018 Jul; 44(7):1002-1011. PubMed ID: 29315149
[TBL] [Abstract][Full Text] [Related]
5. Safety and effectiveness of small and large gel-particle hyaluronic acid in the correction of perioral wrinkles.
Brandt F; Bassichis B; Bassichis M; O'Connell C; Lin X
J Drugs Dermatol; 2011 Sep; 10(9):982-7. PubMed ID: 22052266
[TBL] [Abstract][Full Text] [Related]
6. Safety, Tolerability, and Efficacy of Repeat-Dose Injections of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results from a Prospective, Open-Label, Phase III Study.
Fischer T; Sattler G; Prager W; Rzany B; Pavicic T; Gauglitz G; Weissenberger P; Riaz S
J Drugs Dermatol; 2020 May; 19(5):461-469. PubMed ID: 32484631
[TBL] [Abstract][Full Text] [Related]
7. Effective and Safe Repeated Full-Face Treatments With AbobotulinumtoxinA, Hyaluronic Acid Filler, and Skin Boosting Hyaluronic Acid.
Hedén P; Hexsel D; Cartier H; Bergentz P; Delmar H; Camozzato F; Siega C; Skoglund C; Edwartz C; Norberg M; Kestemont P
J Drugs Dermatol; 2019 Jul; 18(7):682-689. PubMed ID: 31334927
[TBL] [Abstract][Full Text] [Related]
8. HYC-24L Demonstrates Greater Effectiveness With Less Pain Than CPM-22.5 for Treatment of Perioral Lines in a Randomized Controlled Trial.
Butterwick K; Marmur E; Narurkar V; Cox SE; Joseph JH; Sadick NS; Tedaldi R; Wheeler S; Kolodziejczyk JK; Gallagher CJ
Dermatol Surg; 2015 Dec; 41(12):1351-60. PubMed ID: 26606435
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, safety, and patient satisfaction of a monophasic cohesive polydensified matrix versus a biphasic nonanimal stabilized hyaluronic acid filler after single injection in nasolabial folds.
Buntrock H; Reuther T; Prager W; Kerscher M
Dermatol Surg; 2013 Jul; 39(7):1097-105. PubMed ID: 23506356
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of IncobotulinumtoxinA for the treatment of platysmal bands of the aging neck: an open-label, prospective pilot study.
Gubanova EI; Panova OS; Sanchez EA; Rodina MY; Starovatova PA
J Drugs Dermatol; 2013 Dec; 12(12):1461-6. PubMed ID: 24301249
[TBL] [Abstract][Full Text] [Related]
11. Nonsurgical correction of drooping mouth corners using monophasic hyaluronic acid and incobotulinumtoxinA.
Bae GY; Na JI; Park KC; Cho SB
J Cosmet Dermatol; 2020 Feb; 19(2):338-345. PubMed ID: 31125173
[TBL] [Abstract][Full Text] [Related]
12. A multicenter study of the safety and effectiveness of hyaluronic acid with a cohesive polydensified matrix for treatment of nasolabial folds in subjects with Fitzpatrick skin types IV, V, and VI.
Downie JB; Grimes PE; Callender VD
Plast Reconstr Surg; 2013 Oct; 132(4 Suppl 2):41S-47S. PubMed ID: 24077010
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Upper Facial Lines: Results From a Randomized, Double-Blind, Placebo-Controlled, Phase III Study.
Kerscher M; Rzany B; Prager W; Turnbull C; Trevidic P; Inglefield C
Dermatol Surg; 2015 Oct; 41(10):1149-57. PubMed ID: 26359996
[TBL] [Abstract][Full Text] [Related]
14. Cohesive Polydensified Matrix
Gauglitz G; Steckmeier S; Pötschke J; Schwaiger H
Clin Cosmet Investig Dermatol; 2017; 10():507-513. PubMed ID: 29276401
[TBL] [Abstract][Full Text] [Related]
15. Correction of tear trough deformity with a cohesive polydensified matrix hyaluronic acid: a case series.
Huber-Vorländer J; Kürten M
Clin Cosmet Investig Dermatol; 2015; 8():307-12. PubMed ID: 26170706
[TBL] [Abstract][Full Text] [Related]
16. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
Beer KR; Julius H; Dunn M; Wilson F
J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
[TBL] [Abstract][Full Text] [Related]
17. Clinical Validation of Superficial Lip Injections Utilizing Cohesive Polydensified Matrix Hyaluronic Acid-Based Soft Tissue Fillers.
Goldie K; Voropai D; Tzaribachev N; Hilven P; Frank K; Cotofana S; Mosahebi A
J Drugs Dermatol; 2021 Sep; 20(9):940-945. PubMed ID: 34491025
[TBL] [Abstract][Full Text] [Related]
18. A prospective open-label, multicentre study evaluating a non-cross-linked hyaluronic acid based soft-tissue filler in the correction of lateral canthal and perioral lines.
Sulovsky M; Müller D; Prinz V; Moellhoff N; Cajkovsky M; Duschek N; Frank K
J Cosmet Dermatol; 2022 Jan; 21(1):191-198. PubMed ID: 34559948
[TBL] [Abstract][Full Text] [Related]
19. Correction of Tear Trough Deformity With a Cohesive Polydensified Matrix Hyaluronic Acid: A Case Series.
Huber-Vorländer J; Kürten M
Plast Surg Nurs; 2015; 35(4):171-6. PubMed ID: 26605822
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Lateral Periorbital Lines with Different Dilutions of IncobotulinumtoxinA.
Muti GF; Basso M
J Clin Aesthet Dermatol; 2017 Sep; 10(9):27-29. PubMed ID: 29344324
[No Abstract] [Full Text] [Related]
[Next] [New Search]
